Skip to main content
Erschienen in: Italian Journal of Pediatrics 1/2024

Open Access 01.12.2024 | Review

Fatal food anaphylaxis in adults and children

verfasst von: Elio Novembre, Mariannita Gelsomino, Lucia Liotti, Simona Barni, Francesca Mori, Mattia Giovannini, Carla Mastrorilli, Luca Pecoraro, Francesca Saretta, Riccardo Castagnoli, Stefania Arasi, Lucia Caminiti, Angela Klain, Michele Miraglia del Giudice

Erschienen in: Italian Journal of Pediatrics | Ausgabe 1/2024

Abstract

Anaphylaxis is a life-threatening reaction characterized by the acute onset of symptoms involving different organ systems and requiring immediate medical intervention. The incidence of fatal food anaphylaxis is 0.03 to 0.3 million/people/year. Most fatal food-induced anaphylaxis occurs in the second and third decades of life. The identified risk factors include the delayed use of epinephrine, the presence of asthma, the use of recreational drugs (alcohol, nicotine, cannabis, etc.), and an upright position. In the United Kingdom (UK) and Canada, the reported leading causal foods are peanuts and tree nuts. In Italy, milk seems to be the most common cause of fatal anaphylaxis in children < 18 years. Fatal food anaphylaxis in Italian children and adolescents almost always occurs outside and is characterized by cardiorespiratory arrest; auto-injectable adrenaline intramuscular was available in few cases. Mortality from food anaphylaxis, especially in children, is a very rare event with stable incidence, but its risk deeply impacts the quality of life of patients with food allergy and their families. Prevention of fatal food anaphylaxis must involve patients and their families, as well as the general public, public authorities, and patients’ associations.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
UK
United Kingdom
US
United States
ICD-10
International Classification of Diseases
WHO
World Health Organization
AA
Authors
CEPIDC
National Mortality Center
AAI
Auto-injectable Adrenaline Intramuscular
SPT
Skin Prick Test
EAACI
Academy of Allergy and Clinical Immunology
OIT
Oral immunotherapy
CMA
Cow’s milk allergy
QoL
Quality of life
LTP
Lipid Transfer Protein

Introduction

Anaphylaxis is a life-threatening reaction characterized by the acute onset of symptoms involving different organ systems and requiring immediate medical intervention [1], which can affect people of any age and can be caused by many types of allergic triggers or, in some cases, can occur without an identifiable cause [1, 2]. The presentation of anaphylaxis is variable, ranging in severity and manifestation, and it usually includes cutaneous, respiratory, gastrointestinal, neurological, and cardiovascular symptoms.
Anaphylaxis-related epidemiological data can differ widely, and variations depend on the definitions used, the study methodology, and the geographical areas in which it occurs. For instance, European data have indicated incidence rates for all-cause anaphylaxis, ranging from 1.5 to 7.9 per 100 000 person/year, with an estimation that 0.3% (95% CI 0.1–0.5) of the population will experience anaphylaxis at some point during their lifetime [3]. It is estimated that 1 in every 3000 inpatients in United States (US) hospitals suffers from an anaphylactic reaction [4].
Fatal anaphylaxis is fortunately quite rare, with a mortality rate of less than 1 death per million inhabitants per year [59]. Mortality is estimated at 0.05–0.51 per million people per year for drug-induced anaphylaxis, at 0.03–0.32 for food-induced anaphylaxis, and at 0.09–0.13 for venom-induced anaphylaxis [1012]. Accurate anaphylaxis mortality data are, however, hampered by the limited recognition of this condition among health professionals, the absence of historical details from eyewitnesses, incomplete death-scene investigations, paucity of specific pathologic findings during the postmortem examination, and the under-notification of anaphylaxis [1315].

Causes of fatal anaphylaxis

Drugs are the most common cause of fatal anaphylaxis in many countries [9, 14, 1620] (Table 1).
Table 1
Studies on fatal anaphylaxis
Study
Nationality/Database
Analysis
N° subjects/Mean age
Causes of death (%)
Study period
Liew et al [9] (2009)
Australia/National database
Retrospective case review based on ICD-10 codes on death certificates
112/Not reported
Probable drugs (38), drugs (20), insect (18), food (6), undetermined (13)
8 years (1997–2005)
Tanno et al [14]  (2012)
Brazil/Brazilian Mortality Information System
Population-based epidemiologic study using ICD codes on death certificates
498/Not reported
Drugs (42), insect (35), unspecified (21), food (2)
3 years (2008–2010)
Jerschow et al [18] (2014)
USA/United States Vital Statistic Data
Population-based epidemiologic study using ICD CM diagnostic codes on death certificates
2,458 / > 50 years (cause -reported)
Drugs (58.8), unspecified (19.3), venom (15.2), food (6.7)
11 years (1999–2010)
Turner et al [16] (2015)
UK /UK Office on National Statistics database
Hospital admission and fatalities caused by anaphylaxis. Data on anaphylaxis cross-checked against a prospective fatal anaphylaxis registry based on ICD-9 and ICD-10
480/The mean age of fatal food-induced cases ofanaphylaxis was 25 years;  
The mean age of fatal cases of anaphylaxis due to iatrogenic causes was 58 years; 
The mean age of fatal cases by sting-induced anaphylaxis was 59 years
Drugs (54.8), food (25.8), insect (19.3)
20 years (1992–2012)
Bilò et al [17] (2020)
Italy/National Register of Causes of Death database, managed by the Italian National Institute of Statistics
Descriptive study
An analytical method was developed  to identify all the ICD-10 codes related to anaphylaxis deaths, which were divided  into two classes: "definite anaphylaxis deaths” and “possible anaphylaxis deaths”
392 definite anaphylaxis deaths and 220 possible  anaphylaxis deaths were recorded/ Not reported
Drugs (73.7), unspecified  causes (20.7), Hymenoptera stings (5.6)
14 years  (2004–2016)
Xu et al [19] (2014)
Canada/Data from the Ontario Coroner’s database
Retrospective case-series analysis of all causes of anaphylaxis-related deaths using data from the Ontario Coroner’s database
92 / Mean age 46.5 years [age range 9 to  86 years]
Food (43), insect (33), drugs (17), unclear (7)
26 years  (1986–2011)
Poussels et al [20] (2023)
France/Allergy-Vigilance® Network
Retrospective analysis
25 / Not reported
Food (76), drugs (14), Hymenoptera (12)
19 years (2002–2020)
In a study of anaphylaxis-related mortality coming from an official database of the whole Italian population [17], 392 definite anaphylaxis deaths and 220 possible anaphylaxis deaths (7 of which were children) were recorded in 12 years. The cause of death referred to in this study is the underlying trigger of anaphylaxis and was selected according to the rules and provisions of the tenth revision of the International Classification of Diseases (ICD-10) provided by the World Health Organization (WHO). The average mortality rate for definite anaphylaxis from 2004 to 2016 was 0.51 per million people per year. Definite fatal anaphylaxis was mostly due to the use of drugs (73.7%), followed by unspecified causes (20.7%) and Hymenoptera stings (5.6%). Surprisingly, no cases of fatal anaphylaxis from food were found. This, as reported by the same authors (AA), was probably due to an incorrect coding of food anaphylaxis deaths. On the other hand, some reports in which ICD codes were not used suggested that in some countries, food allergies may be a leading cause of fatal anaphylaxis [21].
In Canada, a retrospective case-series analysis of all causes of anaphylaxis-related deaths using data from the Ontario Coroner’s database between 1986 and 2011 [19] found 92 deaths in the last 26 years. Causes of death, in order of decreasing frequency, included food (40 cases), insect venom (30 cases), iatrogenic (16 cases), and idiopathic (6 cases). No data on pediatric age were reported.
In a recent study from France network vigilance [20], 25 deaths (13 were in children < 18 years) were identified in the 2002–2020 period. Causes of death were food (19 cases), drugs (3 cases), and insects (3 cases). The patients who died were younger (25.6 vs. 40.8 years; p = 0.01) than the survivors and mostly presented bronchospasm (56% vs. 29%; p = 0.05).
Therefore, the role of foods in fatal anaphylaxis could be reevaluated.

Incidence of food-induced fatal anaphylaxis

In population-based studies, the rate of fatal anaphylaxis triggered by foods ranges from 0.03 to 0.3 million/people per year. The reported leading causal foods were peanuts and tree nuts [10] (Table 2).
Table 2
Studies on the triggers and risk factors of food fatal anaphylaxis
Study
Nationality/Database
Analysis
Time period
Total deaths
Rate of fatal food (per million/year)
Age
Causal foods
Risk factors
Mullins et al [22] (2016)
Australia/Data  collected from the Australian Bureau of Statistics (ABS) 1997–2013 and the National Coronial Information System (NCIS) 2000- 2013
Retrospective
1997–2013
2000–2013
324 anaphylaxis fatalities in the period
1997–2013, food (n = 23)
1997:0
2014:0.09
Median age 28 (range 4–66)
Seafood 50%, nuts 32%
Known food allergy 91%, asthma 68%, alcohol or recreational drugs 27%, upright posture 68%, delayed use of epinephrine
Xu et al [19] (2014)
Canada/Data from the Ontario Coroner’s database
Retrospective
1986- 2011
92 total, food in 40(43%)
1986:0.32
2011:0.08
Mean age 32 (range 9–78)
Peanuts, tree nuts (55%)
Known food allergy, delayed use of epinephrine
Turner et al [16] (2015)
UK/Data from national databases recording hospital admissions and fatalities caused by anaphylaxis in England and Wales
Retrospective
1992–2012
480 total, food 124(26%)
1992:0–10
2012:0–12
Mean age 25, median age 20. Range (4–85)
Peanuts or tree nuts (73%)
Known food allergy, asthma 78%, change in posture
Recent studies suggest an increase in non-fatal food anaphylaxis [6, 16, 19], but there is no increase in fatalities, except those reported in one Australian study [23].
On the other side, in a UK analysis of national data from 1998–2018, the case fatality rate decreased from 0.7% to 0.19% for confirmed food-induced fatal anaphylaxis [24].

Risk factors of food-induced fatal anaphylaxis

In infants and young children, food-induced fatal anaphylaxis is very rare, although this age group has the highest rates of anaphylaxis [6, 22].
Most food-induced fatal anaphylaxis occur in the second and third decades of life, without a clear explanation. It may be attributed in part to increased risk-taking behavior and lack of available epinephrine. The identified risk factors include the delayed use of epinephrine [25], the presence of asthma, the use of recreational drugs (alcohol, nicotine, cannabis, etc.), and the upright position. There are many reasons for the delayed use of epinephrine, including lack of knowledge (missed diagnosis, improper technique, etc.), lack of access (epinephrine unavailable, epinephrine never obtained, etc.), or lack of use despite availability. The delayed use of epinephrine is the risk factor most amenable to modification, and increasing efforts are needed to provide epinephrine autoinjectors to all subjects at risk of anaphylaxis. Nevertheless, fatal reactions can occur despite timely administration of adrenaline, accounting for up to one‐third of the cases in the UK Fatal Anaphylaxis registry [26].
About 70–75% of subjects who died from food-related anaphylaxis are asthmatics [16, 22], and most cases of fatal food anaphylaxis are characterized by severe respiratory symptoms. Asthma control should, therefore, be optimized in these subjects, although in some studies there is little evidence for an association with poor asthma control or worsening asthma symptoms leading up to the fatal event [16].
The use of alcohol or other recreational drugs may, through disinhibition, increase the likelihood of accidental allergen exposure, mask the early warning signs of anaphylaxis, or suppress physiological responses to hypotension [10]. Upright posture has also been reported as a risk factor [16, 22], suggesting significant cardiovascular compromise. Fatal food anaphylaxis occurs more often in people with a known food allergy. However, prior reactions are not usually severe, and the severity of prior reactions does not appear to be a risk factor for fatal anaphylaxis [27]. Other risk factors that have been proposed, although without consistent evidence, include race (increased risk in African Americans and UK-resident South Asians), allergy to multiple foods, exercise, and intercurrent illness [10].

Food fatal anaphylaxis in children

In the last years, few descriptive studies have reported pediatric anaphylaxis fatalities, and most of them are small case series (Table 3).
Table 3
Trigger foods in fatal anaphylaxis in children
AA
Source/Period
Total N° of Fatal Food
Causal Food
Sampson [28] (1992) USA
-
6
5 peanuts/tree nuts
1 milk/ egg
MacDougal [29] (2002) UK
1990–2000
8
4 milk
2 peanut
1 egg
1 mixed food
Calvani [30] (2006) Italy
Ministerial data/2000–2002
1
Not specified
Bock [31] (2007) USA
Registry kept by members of the American Academy of Allergy, Asthma & Immunology/2001–2006
17
12 peanuts/tree nuts
4 milk
1 not specified
Levi [32] (2012) Israel
All medical and media data reported 2004–2011
3
3 milk
Poussel [33] (2023) France
France/Allergy-Vigilance® Network
13
Not specified
Sampson [28] reported 6 cases of fatal anaphylaxis in children < 6 years. Peanuts or tree nuts were involved in 5 of the 6 cases. All had a previous allergic reaction.
Another study from the UK and Ireland conducted a retrospective search through death certifications at national statistics offices for fatalities in children 0–15 years from 1990 to February 1998, along with a prospective survey of fatal and severe reactions from March 1998 to February 2000 via the British Paediatric Surveillance Unit. Fatal food-induced anaphylaxis was reported in 8 cases. Milk was the cause of fatal anaphylaxis in 4 children [29].
Calvani et al. [30] found only 2 cases of fatal anaphylaxis in children (1 due to food allergy) in the 2000 – 2002 period using ministerial data.
Bock [31] reported 31 fatalities caused by anaphylactic reactions to food between 2001–2006 in a registry kept by members of the American Academy of Allergy, Asthma & Immunology and The Food Allergy and Anaphylaxis Network. Peanuts/tree nuts were responsible in 12 and milk in 4 of the 17 fatalities in subjects <  = 18 years.
Levi et al. [32] described 4 cases of food allergy-related mortality that were known to medical personnel or were published in the Israeli national communications media in an 8-year period: 3 cases were due to cow's milk (all in children), and 1 adult case was due to hazelnut. All episodes occurred outside (party, restaurant, school, bakery). All 3 children were exposed to a hidden/non-obvious milk allergen (quantities of several mg in 2 cases and 180 mg in 1). All four had a history of asthma but were not on controller medications, and none had experienced previous non-life-threatening accidental reactions. Food anaphylaxis in the UK: analysis of national data, 1998–2018 [24] considered 101 891 people admitted to hospital for anaphylaxis. Food-induced anaphylaxis was identified as the probable cause in 152 deaths. At least 46% of deaths were triggered by peanut or tree nuts (86 of 187, including 35 deaths in 1992–98). Cow’s milk was responsible for 17 of 66 (26%) deaths in school-age children. In school-age children, cow’s milk was considered the most common single cause of fatal anaphylaxis, despite allergy to cow’s milk being uncommon in older children and adults [20].
Poussel [33], in a descriptive national-based study using mortality data routinely reported to the National Mortality Center (CEPIDC) for the years 1979–2014 and extracted on January 31, 2017, identified 25 cases of fatal food anaphylaxis in France; 13 were in children < 18 years, and in one case, the fatal reaction occurred during a hospital oral food challenge. Another case of fatal anaphylaxis was previously reported in a 3-year-old child during a baked milk challenge test [34]. Moreover, 1 fatal reaction in an asthmatic child after eating a small bit of food (baked milk) as part of a desensitization therapy was reported by Canadian media in 2021 (https://​www.​allergicliving.​com/​2021/​12/​20/​girl-with-milk-allergy-dies-of-severe-reaction-related-to-desensitization/​). Therefore, fatal anaphylaxis occurs after an unnoticed ingestion of allergenic food and exceptionally during diagnostic or therapeutic management of a food allergy. According to these data, the most frequent food allergens involved in fatal anaphylaxis in children are peanuts and tree nuts in the US and milk in the UK and Israel (Table 3).
In the UK, it was found that over the past 25 years, the proportion of fatalities due to peanuts or tree nuts has fallen (attributed to increased awareness of nut allergies by food businesses) and that cow’s milk was the most common cause of fatal anaphylaxis in children [24].
In Italy, a recent study by Bilò et al [17]. found no food fatal anaphylaxis in children or adults. These surprising data were explained by the fact that fatalities due to food do happen to adults; however, they are often not recorded in national registries due to incorrect coding but only reported in national and local newspapers [17]. Cases of food-induced fatal anaphylaxis in children are very rare but occur (Table 3). We collected 9 cases in children < 18 years published by the Italian media between 2010 and 2023 in Italy. 8/9 cases were due to milk allergy and occurred outside the home. Auto-injectable adrenaline intramuscular (AAI) was available only in 3/9 cases.
The mean age was 14 years. Only 1 case occurred in a child < 12 years of age. In many cases, the autopsy confirmed anaphylaxis as the cause of death (Table 4).
Table 4
Cases of fatal food anaphylaxis in children published by the Italian media between 2010 and 2023
Name
Age
Year/Location/City
Allergen
Certain (C) / Suspected (S)
Suspected food
Injectable Adrenaline  available
Autopsy
Other
DP
(M)
16 years
2010 / Restaurant / San Giovanni Rotondo (FG)
Wheat allergy (S), other unspecified food allergies, celiac disease
Ice cream with cereals biscuit
Yes
Late and improper injection
YES
Not available
Restaurant staff informed of allergies
CW 
(M)
7 years
2015 / Restaurant/ Ravello (Sa)
Milk (C)
Homemade (with milk) spaghetti with tomato sauce
Yes
EpiPen injected by the mother (nurse)
Yes
Anaphylactic shock confirmed
Death in Santobono hospital after 3 days
AB
(M)
17 years
2015 / Friend’s house / Gaiole in Chianti (Si)/
Milk (C)
Pasta with tomato and cheese
No
Yes
Anaphylactic shock confirmed
Previous anaphylactic shock at 11 years
BS
(F)
16 years
2018 / Home (Cosenza)
Milk (C)
Licorice candy
No
No
Dyspnea, hypotension, urticaria
MVS
(F)
12 years
2019 / Pizzeria / Villorba (Treviso)
Milk (C)
Pizza
No
Adrenaline injected by parents
Yes
Anaphylactic shock confirmed
Restaurant staff aware of her allergy
FS
(F)
16 years
2019 / Bar / Roma
Milk (S)
Other unspecified allergies
Cocktail (rum, whisky, fruit cream, coconut milk)
Not reported
Yes
Not available
Not available
AA
(M)
17 years
2020 / Friend’s home / Taggia (Imperia)
news/shock-anafilattico-muore-ragazzo-di-17-anni-a-taggia-1.38523834
Milk (C)
Salami sandwich
No
Coroner confirmed cause of death
Similar episode 1 years before
MQ
(F)
13 years
2022/Birthday party with friends (Fondi-Latina)
Milk (C)
Salami sandwich
Yes
Not sure if used right
away
back at home
Yes
(glottis oedema)
Restaurant staff informed of allergy
CP
(F)
16 years
2021/School (Enna)
Milk (C)
Pasta with ragu sauce
Not reported
Yes
Not available
First symptoms at school. Died while waiting for the bus

Milk as a common cause of fatal anaphylaxis in children

Milk allergy is common in childhood and is characterized by a high rate of resolution (50% of the children have tolerance to cow’s milk by 5 years and 75% by the early teenage years) [35]. Persistent milk allergy has been associated with low dose reactions, larger wheal size on Skin Prick Test (SPT) [36], higher serum IgE levels, and a history of anaphylaxis [37]. The persistence of milk allergy has been associated with particular peptide casein sensitization [38]. Cow’s milk has a relatively high protein content, so very low levels of exposure are sufficient to cause reactions. Some described cases of fatal anaphylaxis occurred for hidden minimal quantities (mg) of milk contamination in the ingested food [32].
In the UK and in Italy, milk seems to be the most common cause of fatal anaphylaxis in children < 18. The increasing number of cases of fatal anaphylaxis due to cow's milk in school-age children and young adults and an association between food anaphylaxis and patient's region is also mentioned in the recent European Academy of Allergy and Clinical Immunology (EAACI) guidelines: Anaphylaxis (2021 update) [1].

Management of children at risk of food fatal anaphylaxis

Prevention of food fatal anaphylaxis involves patients and their families as well as the general public, public authorities, and patients’ associations.
a)
Measures involving the general public, public authorities, and patients’ associations.
1)
Developing multiple strategies to improve knowledge of life‐threatening anaphylaxis reactions at both national and international public health levels and improve patient access to care and prevention (through prescription of epinephrine autoinjectors and provision of individualized emergency action plans). Anaphylaxis due to food allergy occurs in schools more than in any other community location [39, 40]. Therefore, it may be helpful to target secondary schools and community settings with educational support to help raise general awareness, empower adolescents to confidently self-manage food allergies, and enable schools to develop protocols to minimize any adverse events that may occur.
 
2)
Optimizing classification and coding for allergic diseases and anaphylaxis. ICD-10 is reported to be an imperfect tool to encode anaphylaxis [17]. The upcoming implementation of the new ICD‐11 classification of allergic and hypersensitivity conditions will be an opportunity to improve anaphylaxis coding to hopefully obtain more accurate data relating to the number of anaphylaxis deaths and their cause.
 
 
b)
Measures involving patients and their families. The reliable identification of patients at increased risk of fatal food anaphylaxis is not currently possible, but some suggestions can be used to help those more likely to have potentially lethal food anaphylaxis:
1)
Information on the role of comorbidities and cofactors. A personal history of asthma is reported in most anaphylaxis fatalities, but no clear relationship has been demonstrated. However, a good control of asthma is mandatory in subjects with food-induced anaphylaxis. The possible role of physical activity and alcohol consumption as cofactors should also be stressed, especially in adolescents and young people who are at greater risk of food-fatal anaphylaxis. The anticipation of higher-risk situations (meals outside the home, school, restaurants, and trips) is also necessary.
 
2)
Promotion of recognition of allergies and foods at risk. Most fatal food reactions are caused by peanuts, tree nuts, and seafood; in children < 18 years of age, a persistent cow’s milk allergy is also described in a significant proportion of severe and fatal anaphylaxis reactions, in particular in England and Israel. In Italy, no fatal food anaphylaxis was reported in a recent epidemiological study, but this was probably due to an incorrect coding of food-induced anaphylaxis deaths. Moreover, some cases of fatal food anaphylaxis were published by the Italian media in the same period [17]. In our study, milk was the most common cause of fatal anaphylaxis in children < 18 as reported by Italian media. Exclusion of the offending food from the diet is the usual recommendation, along with adequate informative labeling of prepackaged and non‐packaged foods from a list of notifiable ingredients. In this regard, every effort should be made, as fatal anaphylaxis usually happens when the known offending allergen is ingested in hidden/non-obvious form and outside the home. Oral desensitization should be discussed with the patient or parents. Oral immunotherapy (OIT) is the only active therapy currently available that could modify the anaphylactic risk of patients with food allergy [41]. OIT was suggested for treating patients who do not spontaneously acquire tolerance at 4–5 years [42]. OIT is effective in a significant percentage of cases [43], but 20% of children with cow’s milk allergy (CMA) are reported to discontinue treatment due to the significant side effects [44]. In a study, older age was significantly related to a higher risk of OIT failure in children with CMA over time [45]. Therefore, in children with persistent milk allergy and OIT failure, particular psychological and practical support is needed. Many studies reported significant improvement in quality of life (QoL) in children undergoing low-dose peanut OIT [46] or OIT maintenance [47]. OIT seems to have a positive effect on the daily life of patients as well as their parents [48]. Moreover, OIT is considered a driver of decreased severity of allergic reactions [49]. In any case, OIT should be performed very cautiously and by expert medical staff, as 1 fatal reaction during desensitization is reported (https://​www.​allergicliving.​com/​2021/​12/​20/​girl-with-milk-allergy-dies-of-severe-reaction-related-to-desensitization/​).
 
3)
Identification of subjects at increased risk of severe reactions is still uncertain. In a recent meta-analysis, IgE sensitization or basophil activation tests were not good predictors [49]. For some foods, molecular allergology may be useful in predicting higher or lower risk of anaphylaxis, particularly when combined with other potential predictors. For tree nuts, IgE against 2S albumins has been reported to be associated with increased rate of any anaphylaxis [49, 50]. A low certain of evidence for an increased risk of severe reactions in food allergy was found for poorly controlled asthma, delayed/inappropriate treatment, use of beta blockers and ACE inhibitors, exercise, and some specific endotypes such as Lipid Transfer Protein (LTP) sensitization and persisting cow milk allergy. Risk of severe outcomes is greatest in adolescence and young adulthood, but the contribution of risk-taking behavior to severe outcomes is unclear. An absence of prior anaphylaxis does not exclude its future risk [51].
 
4)
Clear and accurate explanation of recognition of symptoms of anaphylaxis and proper treatment. Indication for the prescription of adrenaline according to EAACI Guidelines 2022 [1]. AAI continues to be underused to treat anaphylaxis. In adolescents, repeated education, and training on the appropriate use of AAI is necessary [51]. As food fatal anaphylaxis is due to cardiorespiratory arrest and occurs often after several minutes and often outside the home, with delay in proper treatment, 2 AAI should be absolutely prescribed. Particularly in children with persisting cow milk allergy, if the allergen is ingested, AAI should probably be injected earlier than usually recommended [52]. There is also the need to promote the provision of AAI in ambulances and first aid services [53].
 
 

Conclusions

In conclusion, mortality from food anaphylaxis, especially in children, is a very rare event with stable incidence, but it deeply impacts the quality of life of patients with food allergy and their families. In Italian children < 18 years old, milk seems to be the cause of most cases of food-fatal anaphylaxis. In general, all efforts should be made to reduce the risk of fatal food anaphylaxis through general national and international strategies and optimized preventive and medical care in order to choose the best approach for the single patient.

Acknowledgements

Not applicable.

Declarations

Not applicable
Not applicable.

Competing interests

The authors declare that they have no conflict of interests to disclose in relation to this paper.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61.CrossRefPubMed Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353–61.CrossRefPubMed
4.
Zurück zum Zitat Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161:15–21.CrossRefPubMed Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161:15–21.CrossRefPubMed
5.
Zurück zum Zitat Mikhail I, Stukus DR, Prince BT. Fatal anaphylaxis: epidemiology and risk factors. Curr Allergy Asthma Rep. 2021;21:28.CrossRefPubMed Mikhail I, Stukus DR, Prince BT. Fatal anaphylaxis: epidemiology and risk factors. Curr Allergy Asthma Rep. 2021;21:28.CrossRefPubMed
6.
Zurück zum Zitat Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:1075–83.CrossRefPubMed Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol. 2014;133:1075–83.CrossRefPubMed
7.
Zurück zum Zitat Pouessel G, Claverie C, Labreuche J, Dorkenoo A, Renaudin JM, Eb M, et al. Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979–2011. J Allergy Clin Immunol. 2017;140(2):610–2.CrossRefPubMed Pouessel G, Claverie C, Labreuche J, Dorkenoo A, Renaudin JM, Eb M, et al. Fatal anaphylaxis in France: analysis of national anaphylaxis data, 1979–2011. J Allergy Clin Immunol. 2017;140(2):610–2.CrossRefPubMed
8.
Zurück zum Zitat Pumphrey RSH. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116–28. Discussion 128–132, 157–160, 276–285.CrossRefPubMed Pumphrey RSH. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp. 2004;257:116–28. Discussion 128–132, 157–160, 276–285.CrossRefPubMed
9.
Zurück zum Zitat Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434–42.CrossRefPubMed Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol. 2009;123:434–42.CrossRefPubMed
10.
Zurück zum Zitat Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169–78.CrossRefPubMedPubMedCentral Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract. 2017;5(5):1169–78.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global trends in anaphylaxis epidemiology and clinical implications. J Allergy Clin Immunol Pract. 2020;8(4):1169–76.CrossRefPubMedPubMedCentral Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global trends in anaphylaxis epidemiology and clinical implications. J Allergy Clin Immunol Pract. 2020;8(4):1169–76.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ansotegui IJ, Sánchez-Borges M, Cardona V. Current trends in prevalence and mortality of anaphylaxis. Curr Treat Options Allergy. 2016;3:205–11.CrossRef Ansotegui IJ, Sánchez-Borges M, Cardona V. Current trends in prevalence and mortality of anaphylaxis. Curr Treat Options Allergy. 2016;3:205–11.CrossRef
13.
Zurück zum Zitat Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13–37.CrossRefPubMedPubMedCentral Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J. 2011;4(2):13–37.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783–9.CrossRefPubMed Tanno LK, Ganem F, Demoly P, Toscano CM, Bierrenbach AL. Undernotification of anaphylaxis deaths in Brazil due to difficult coding under the ICD-10. Allergy. 2012;67:783–9.CrossRefPubMed
15.
Zurück zum Zitat Sharma V, Garcez T, Fox AT. Fatal anaphylaxis: making sure alla cases are counted. BMJ. 2021;372:n691.CrossRefPubMed Sharma V, Garcez T, Fox AT. Fatal anaphylaxis: making sure alla cases are counted. BMJ. 2021;372:n691.CrossRefPubMed
16.
Zurück zum Zitat Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956-63.e1.CrossRefPubMedPubMedCentral Turner PJ, Gowland MH, Sharma V, Ierodiakonou D, Harper N, Garcez T, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956-63.e1.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Bilò MB, Corsi A, Martini M, Penza E, Grippo F, Bignardi D. Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004–2016. Allergy. 2020;75:2644–52.CrossRefPubMed Bilò MB, Corsi A, Martini M, Penza E, Grippo F, Bignardi D. Fatal anaphylaxis in Italy: analysis of cause-of-death national data, 2004–2016. Allergy. 2020;75:2644–52.CrossRefPubMed
19.
Zurück zum Zitat Xu YS, Kastner M, Harada L, Xu A, Salter J, WasermanS. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from,. to 2011. Allergy Asthma Clin Immunol. 1986;2014(10):38. Xu YS, Kastner M, Harada L, Xu A, Salter J, WasermanS. Anaphylaxis-related deaths in Ontario: a retrospective review of cases from,. to 2011. Allergy Asthma Clin Immunol. 1986;2014(10):38.
21.
Zurück zum Zitat Michelson KA, Dribin TE, Vyles D, Neuman MI. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767-768.e2.CrossRefPubMed Michelson KA, Dribin TE, Vyles D, Neuman MI. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract. 2020;8(2):767-768.e2.CrossRefPubMed
22.
Zurück zum Zitat Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46:1099–110.CrossRefPubMed Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy. 2016;46:1099–110.CrossRefPubMed
23.
Zurück zum Zitat Turner PJ, Campbell DE. Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis? Curr Opin Allergy Clin Immunol. 2016;16:441–50.CrossRefPubMedPubMedCentral Turner PJ, Campbell DE. Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis? Curr Opin Allergy Clin Immunol. 2016;16:441–50.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Baseggio Conrado A, Ierodiakonou D, Gowland MH, Boyle RJ, Turner PJ. Food anaphylaxis in the United Kingdom: analysis of nationaldata, 1998–2018. BMJ. 2021;372:n251.CrossRefPubMedPubMedCentral Baseggio Conrado A, Ierodiakonou D, Gowland MH, Boyle RJ, Turner PJ. Food anaphylaxis in the United Kingdom: analysis of nationaldata, 1998–2018. BMJ. 2021;372:n251.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082–123.CrossRefPubMed Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020;145(4):1082–123.CrossRefPubMed
26.
Zurück zum Zitat Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol. 2007;119:1018–9.CrossRefPubMed Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999–2006. J Allergy Clin Immunol. 2007;119:1018–9.CrossRefPubMed
27.
Zurück zum Zitat Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4:285–90.CrossRefPubMed Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol. 2004;4:285–90.CrossRefPubMed
29.
Zurück zum Zitat Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002;86:236–9.CrossRefPubMedPubMedCentral Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002;86:236–9.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Calvani M, Di Lallo D, Spinelli A, Polo A. Epidemiologia della anafilassi in Italia. Rivista di Immunologia e Allergologia Pediatrica. 2006;5:23–8. Calvani M, Di Lallo D, Spinelli A, Polo A. Epidemiologia della anafilassi in Italia. Rivista di Immunologia e Allergologia Pediatrica. 2006;5:23–8.
32.
Zurück zum Zitat Levy MB, Goldberg MR, Nachshon L, Tabachnik E, Katz Y. Lessons from cases of mortality due to food allergy in Israel: cow’s milk protein should be considered a potentially fatal allergen. Isr Med Assoc J. 2012;14(1):29–33.PubMed Levy MB, Goldberg MR, Nachshon L, Tabachnik E, Katz Y. Lessons from cases of mortality due to food allergy in Israel: cow’s milk protein should be considered a potentially fatal allergen. Isr Med Assoc J. 2012;14(1):29–33.PubMed
34.
Zurück zum Zitat Cox AL, Nowak-Wegrzyn A. Innovation in food challenge tests for food allergy. Curr Allergy Asthma Rep. 2018;18(12):74.CrossRefPubMed Cox AL, Nowak-Wegrzyn A. Innovation in food challenge tests for food allergy. Curr Allergy Asthma Rep. 2018;18(12):74.CrossRefPubMed
35.
Zurück zum Zitat Spergel JM. Natural history of cow’s milk allergy. J Allergy Clin Immunol. 2013;131:813–4.CrossRefPubMed Spergel JM. Natural history of cow’s milk allergy. J Allergy Clin Immunol. 2013;131:813–4.CrossRefPubMed
39.
Zurück zum Zitat Greenhawt M. Environmental exposure to peanut and the risk of an allergic reaction. Ann Allergy Asthma Immunol. 2018;120(5):476-481.e473.CrossRefPubMed Greenhawt M. Environmental exposure to peanut and the risk of an allergic reaction. Ann Allergy Asthma Immunol. 2018;120(5):476-481.e473.CrossRefPubMed
40.
Zurück zum Zitat Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046–57.CrossRefPubMed Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, et al. EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community. Allergy. 2014;69(8):1046–57.CrossRefPubMed
41.
Zurück zum Zitat Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72:1133–47.CrossRefPubMed Nurmatov U, Dhami S, Arasi S, Pajno GB, Fernandez-Rivas M, Muraro A, et al. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72:1133–47.CrossRefPubMed
42.
Zurück zum Zitat Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799–815.CrossRefPubMed Pajno GB, Fernandez-Rivas M, Arasi S, Roberts G, Akdis CA, Alvaro-Lozano M, et al. EAACI guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy. 2018;73:799–815.CrossRefPubMed
43.
Zurück zum Zitat Vazquez-Ortiz M, Turner PJ. Improving the safety of oral immunotherapy for food allergy. Pediatr Allergy Immunol. 2016;27:117–25.CrossRefPubMed Vazquez-Ortiz M, Turner PJ. Improving the safety of oral immunotherapy for food allergy. Pediatr Allergy Immunol. 2016;27:117–25.CrossRefPubMed
45.
Zurück zum Zitat Benelli E, Trombetta A, Badina L, Andrade S, Zamagni G, Prisco A, et al. Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy. Immun Inflamm Dis. 2022;10:e668.CrossRefPubMedPubMedCentral Benelli E, Trombetta A, Badina L, Andrade S, Zamagni G, Prisco A, et al. Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy. Immun Inflamm Dis. 2022;10:e668.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, et al. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol Pract. 2019;7:479-491.e10.CrossRefPubMed Blumchen K, Trendelenburg V, Ahrens F, Gruebl A, Hamelmann E, Hansen G, et al. Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol Pract. 2019;7:479-491.e10.CrossRefPubMed
47.
Zurück zum Zitat Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Quality of life of food-allergic patients before, during, and after oral immuno- therapy. J Allergy Clin Immunol Pract. 2019;7:429-436.e2.CrossRefPubMed Epstein-Rigbi N, Goldberg MR, Levy MB, Nachshon L, Elizur A. Quality of life of food-allergic patients before, during, and after oral immuno- therapy. J Allergy Clin Immunol Pract. 2019;7:429-436.e2.CrossRefPubMed
49.
Zurück zum Zitat Turner PJ, Arasi S, Ballmer-Weber B, Baseggio Conrado A, Deschildre A, Gerdts J, et al. Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis. Allergy. 2022;77(9):2634–52.CrossRefPubMed Turner PJ, Arasi S, Ballmer-Weber B, Baseggio Conrado A, Deschildre A, Gerdts J, et al. Risk factors for severe reactions in food allergy: rapid evidence review with meta-analysis. Allergy. 2022;77(9):2634–52.CrossRefPubMed
50.
Zurück zum Zitat Lyons SA, Datema MR, Le TM, Asero R, Barreales R, Belohlavkova S, et al. Walnut allergy across Europe:distribution of allergen sensitization patterns and prediction of severity. J Allergy Clin Immunol Pract. 2021;9(1):225-235.e10.CrossRefPubMed Lyons SA, Datema MR, Le TM, Asero R, Barreales R, Belohlavkova S, et al. Walnut allergy across Europe:distribution of allergen sensitization patterns and prediction of severity. J Allergy Clin Immunol Pract. 2021;9(1):225-235.e10.CrossRefPubMed
52.
Metadaten
Titel
Fatal food anaphylaxis in adults and children
verfasst von
Elio Novembre
Mariannita Gelsomino
Lucia Liotti
Simona Barni
Francesca Mori
Mattia Giovannini
Carla Mastrorilli
Luca Pecoraro
Francesca Saretta
Riccardo Castagnoli
Stefania Arasi
Lucia Caminiti
Angela Klain
Michele Miraglia del Giudice
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
Italian Journal of Pediatrics / Ausgabe 1/2024
Elektronische ISSN: 1824-7288
DOI
https://doi.org/10.1186/s13052-024-01608-x

Weitere Artikel der Ausgabe 1/2024

Italian Journal of Pediatrics 1/2024 Zur Ausgabe

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

29.05.2024 Reanimation im Kindesalter Nachrichten

Laut einer Studie aus den USA und Kanada scheint es bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Ob ungeborene Kinder, die kleiner als die meisten Gleichaltrigen sind, schneller wachsen, wenn die Mutter sich mehr ausruht, wird diskutiert. Die Ergebnisse einer US-Studie sprechen dafür.

Bei Amblyopie früher abkleben als bisher empfohlen?

22.05.2024 Fehlsichtigkeit Nachrichten

Bei Amblyopie ist das frühzeitige Abkleben des kontralateralen Auges in den meisten Fällen wohl effektiver als der Therapiestandard mit zunächst mehrmonatigem Brilletragen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.